BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 28, 2026
See today's BioWorld
Home
» Other news to note for March 16, 2021
To read the full article
sign up for free
or
sign in
.
Other news to note for March 16, 2021
March 16, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Alchemab, Allero, Ampio, Astrazeneca, Atai, Boehringer, Can-Fite, Cohbar, Cure, Diverse, Elevation Oncology, Enveric, Evaxion, Ewopharma, GBT, Horizon, Immunoprecise, Immutep, Intelgenx, Italfarmaco, Luye, Merck & Co., Neogenomics, Nurix, Otsuka, Pandion, Perception, Purdue, Sanofi, Skye, Viela.
BioWorld
Briefs
Other news to note
Coronavirus